As coronavirus variants spread, FDA drawing up guidance for adjusted vaccines, diagnostics

Amid emerging coronavirus variants, the Food and Drug Administration (FDA) is drafting guidance to help companies tweak vaccines, therapeutics and tests, should that need arise.